Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-30 @ 4:08 PM
Study NCT ID:
NCT01139593
Status:
COMPLETED
Last Update Posted:
2015-12-09
First Post:
2010-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)
Sponsor:
Virginia Center for Reproductive Medicine
Organization:
Study Overview
Official Title:
A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: